Difference between revisions of "Team:Hong Kong HKU"
Louislo3412 (Talk | contribs) |
Louislo3412 (Talk | contribs) |
||
| Line 6: | Line 6: | ||
<div class="column full_size" > | <div class="column full_size" > | ||
<h2> HKU iGEM Team 2016 </h2> | <h2> HKU iGEM Team 2016 </h2> | ||
| + | </div> | ||
</html> | </html> | ||
[[Team:Hong_Kong_HKU/Description|You are welcome to visit our description page here!]] | [[Team:Hong_Kong_HKU/Description|You are welcome to visit our description page here!]] | ||
| − | < | + | ==Project description== |
| − | </ | + | <br> |
| + | ==Inspiration== | ||
| + | ===Early diagnosis of cancer=== | ||
| + | Cancer has always been a devastating disease. In 2012, there were 14.1 million new cancer cases worldwide.<ref name="American Cancer Society">American Cancer Society. (2015). Global Cancer Facts & Figures. Retrieved from http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-044738.pdf</ref> Early diagnosis of cancer may help to reduce the mortality rate and extend the life expectancy of patients. For instance, in the U. K., nearly 90% of patients diagnosed with stage I lung cancer lived for more than a year while only 19% of patients diagnosed at stage IV do so.<ref name="Public Health England">Public Health England. (2014). National Cancer Intelligence Network Cancer survival in England by stage. Retrieved from http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/survival#ref-3 </ref> Early diagnosis of cancer is also believed to be vital for successful treatment and recovery. | ||
| − | < | + | Significant gene mutations might indicate the possibility of development of cancers. Although recent research has diagnosed cancers by analyzing individual genetic mutation profiles<ref name="Pereira, B., Chin, S., Rueda, O. M., Vollan, H. M., Provenzano, E., Bardwell, H. A., Pugh, M., et al.">Pereira, B., Chin, S., Rueda, O. M., Vollan, H. M., Provenzano, E., Bardwell, H. A., Pugh, M., et al. (2016). The somatic mutation profiles of 2500 primary breast cancers refine their genomic landscapes. Nature Communications</ref>,<ref name="Pereira, B., Chin, S. F., Rueda, O. M., Vollan, H. K. M., Provenzano, E., Bardwell, H. A., ... & Tsui, D. W.">Pereira, B., Chin, S. F., Rueda, O. M., Vollan, H. K. M., Provenzano, E., Bardwell, H. A., ... & Tsui, D. W. (2016). The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nature communications, 7.</ref>, such diagnostic method takes up considerable amount of time to obtain accurate results. As conventional diagnostic methods involve complicated procedures, DNA nanostructures have been introduced to detect cancer biomarkers to facilitate simple diagnosis. |
| − | + | <br> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | < | + | |
| − | + | ||
| − | < | + | <br> |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | < | + | ===DNA nanostructures and miRNAs as biomarkers=== |
| − | + | DNA has emerged as a promising material that allows researchers to construct novel designs as its structure could be predicted easily and accurately.<ref name="Chen, Y. J., Groves, B., Muscat, R. A., & Seelig, G.">Chen, Y. J., Groves, B., Muscat, R. A., & Seelig, G. (2015). DNA nanotechnology from the test tube to the cell. Nature nanotechnology, 10(9), 748-760.</ref> Examples of DNA nanostructures include nano-tweezers to detect norovirus and a DNA ‘Nano-Claw’ to detect membrane markers of cancer cells.<ref name="Nakatsuka, K., Shigeto, H., Kuroda, A., & Funabashi, H. ">Nakatsuka, K., Shigeto, H., Kuroda, A., & Funabashi, H. (2015). A split G-quadruplex-based DNA nano-tweezers structure as a signal-transducing molecule for the homogeneous detection of specific nucleic acids. Biosensors and Bioelectronics, 74, 222-226.</ref>,<ref name="You, M., Peng, L., Shao, N., Zhang, L., Qiu, L., Cui, C., & Tan, W.">You, M., Peng, L., Shao, N., Zhang, L., Qiu, L., Cui, C., & Tan, W. (2014). DNA “nano-claw”: logic-based autonomous cancer targeting and therapy. Journal of the American Chemical Society, 136(4), 1256-1259.</ref> | |
| − | + | ||
| − | </ | + | DNA Boolean logic gates have been constructed to produce signals in the presence of multiple targets, such as OR-gate and AND-gate DNA tetrahedra that generate fluorescence resonance energy transfer (FRET) signal when multiple inputs hybridize with the probe.<ref name="Pei, H., Liang, L., Yao, G., Li, J., Huang, Q., & Fan, C.">Pei, H., Liang, L., Yao, G., Li, J., Huang, Q., & Fan, C. (2012). Reconfigurable Three‐Dimensional DNA Nanostructures for the Construction of Intracellular Logic Sensors. Angewandte Chemie, 124(36), 9154-9158.</ref> |
| + | As for the targets to be detected, different microRNAs (miRNAs) have been identified to be associated with cancers. For example, miR-15b-5p, miR-338-5p, and miR-764 found in plasma are potential biomarkers for detecting hepatocellular carcinoma cancer (HCC), a common type of liver cancer.<ref name="Chen, Y., Chen, J., Liu, Y., Li, S., & Huang, P.">Chen, Y., Chen, J., Liu, Y., Li, S., & Huang, P. (2015). Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Medical science monitor: international medical journal of experimental and clinical research, 21, 1864.</ref> It has already been reported that it is promising to use these biomarkers - miRNAs to detect cancers.<ref name="Montani, F., & Bianchi, F.">Montani, F., & Bianchi, F. (2016). Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA. EBioMedicine, 5, 4-6.</ref> | ||
| + | <br> | ||
| + | <br> | ||
| + | ==Objectives== | ||
| + | ===''In vivo'' synthesis of functional DNA nanostructure=== | ||
| + | Our aim is to design a novel DNA nanostructure that can detect multiple miRNA targets simultaneously. We hope that our design can discriminate a single base mutation of the target miRNAs. Hence, it can be highly specific to our targets and avoid false positives. Our goal is clear - we aim to design a tool which can possibly detect a combination of biomarkers and enhance the sensitivity of detecting a particular type of cancer. | ||
| − | < | + | Recently, ''in vitro'' applications of DNA nanostructure have already achieved point-of-care (POC) diagnosis<ref name="Hartman, Mark R., et al.">Hartman, Mark R., et al.(2013) . "Point-of-care nucleic acid detection using nanotechnology." Nanoscale 5.21 (2013): 10141-10154.</ref>. Therefore, we hope to move from ''in vitro'' to ''in vivo'' by developing a self-assembled DNA nanostructure that can potentially target miRNAs ''in vivo''. Detecting serum miRNA can be challenging because of the low serum miRNA level, so methods such as quantitative polymerase chain reaction are used to amplify the target miRNAs before detecting them.<ref name="Wang. W.T.,Chen.Y.Q. ">Wang. W.T., Chen.Y.Q. (2014). "Circulating miRNAs in cancer: from detection to therapy." Journal of Hematology & Oncology. (2014): Vol.7. 86.</ref> We hope that our DNA nanostructure, which is synthesized and assembled ''in vivo'', can potentially eliminate the need of target amplification. |
| − | < | + | In addition, our design has an advantage over the current designs of molecular beacon. Molecular beacon makes use of fluorophores and quenchers<ref name="TSOURKAS, Andrew, et al. ">TSOURKAS, Andrew, et al. (2003). Hybridization kinetics and thermodynamics of molecular beacons. Nucleic acids research, 2003, 31.4: 1319-1330.</ref>, which cannot be synthesized ''in vivo''. Our design does not require the use of fluorophore and quencher and thus can work well inside cells. In addition, our DNA nanostructure can be produced at a lower cost as fluorophore and quencher are not used. |
| − | < | + | [[File:HKU ProjectDescription Mindmap1.jpg|center|1052px]] |
| − | + | <br> | |
| − | + | ==Current progress== | |
| + | Our design is a 3-dimensional structure that can be self-assembled from oligonucleotides. Our aim is to construct a nanostructure that is able to detect multiple miRNA biomarkers such that it can reach a higher accuracy for diagnosis. For the selection of biomarkers, we are looking for a combination of miRNAs that are specific to a certain type of disease including cancers. | ||
| + | At current stage, we are testing different designs ''in vitro'' to see if they can produce desired signals. After proving our designs can work ''in vitro'', we will attempt to test them ''in vivo''. Finally, we will design a mechanism such that E. coli can synthesize the required oligonucleotides to form the specified nanostructure. | ||
| + | [[File:HKU ProjectDescription Mindmap2.jpg|center]] | ||
| + | <br> | ||
| − | + | ==Signifcance== | |
| − | + | ===A leap forward - ''in vivo'' synthesis of 3D functional DNA nanostructures=== | |
| − | + | In the past decade, functional DNA nanostructures have been used in similar ''in vitro'' approaches to detect various cancer biomarkers.<ref name="Miao, P., Wang, B., Chen, X., Li, X., & Tang, Y.">Miao, P., Wang, B., Chen, X., Li, X., & Tang, Y. (2015). Tetrahedral DNA nanostructure-based microRNA biosensor coupled with catalytic recycling of the analyte. ACS applied materials & interfaces, 7(11), 6238-6243.</ref><ref name="Li W. et. al.">Li W. et. al. (2015). Highly selective and sensitive detection of miRNA based on toehold-mediated strand displacement reaction and DNA tetrahedron substrate. Biosensors and Bioelectronics. 71, 401-406.</ref>It is noted that most of those designs were applied ''in vitro''. Recently, 1D and 2D DNA structures were successfully expressed and assembled ''in vivo'',<ref name="Elbaz, J., Yin, P., & Voigt, C. A.">Elbaz, J., Yin, P., & Voigt, C. A. (2016). Genetic encoding of DNA nanostructures and their self-assembly in living bacteria. Nature communications, 7.</ref> while several novel 3D DNA structures were synthesized to produce signals ''in vivo''.<ref name="Kim K. et. al.">Kim K. et. al. (2013). Drug delivery by self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells. Chem. Commun. 49, 2010-2012.</ref>,<ref name="Kim K. et. al">Kim K. et. al. (2013). Sentinel lymph node imaging by a fluorescently labeled DNA tetrahedron. Biomaterials. 34, 5226-5235.</ref> Given these advancements, our ultimate goal is to enable our functional DNA nanostructure to be synthesized and self-assembled in E. coli, that can function inside the disease cells. This, if successful and with further refinement, could be a great replacement to colour coded surgery in the surgical field.<ref name="Nguyen, Q. T., & Tsien, R. Y.">Nguyen, Q. T., & Tsien, R. Y. (2013). Fluorescence-guided surgery with live molecular navigation [mdash] a new cutting edge. Nature reviews cancer, 13(9), 653-662.</ref> | |
| − | + | ||
| − | + | ||
| − | < | + | |
| − | < | + | |
| − | < | + | |
| − | < | + | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | </ | + | |
| + | Last but not least, the cost and quality of production, efficiency and accuracy of our intracellularly-synthesized 3D structure will be compared to current diagnostic methods. | ||
| + | <br> | ||
| + | ---- | ||
| − | + | ==References== | |
| − | + | <br> | |
| − | + | <div class="references-small"> <references /> </div> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | <div class=" | + | |
| − | + | ||
| − | </ | + | |
| − | + | ||
| − | </div | + | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
Revision as of 07:39, 1 July 2016
HKU iGEM Team 2016
Contents
Project description
Inspiration
Early diagnosis of cancer
Cancer has always been a devastating disease. In 2012, there were 14.1 million new cancer cases worldwide.[1] Early diagnosis of cancer may help to reduce the mortality rate and extend the life expectancy of patients. For instance, in the U. K., nearly 90% of patients diagnosed with stage I lung cancer lived for more than a year while only 19% of patients diagnosed at stage IV do so.[2] Early diagnosis of cancer is also believed to be vital for successful treatment and recovery.
Significant gene mutations might indicate the possibility of development of cancers. Although recent research has diagnosed cancers by analyzing individual genetic mutation profiles[3],[4], such diagnostic method takes up considerable amount of time to obtain accurate results. As conventional diagnostic methods involve complicated procedures, DNA nanostructures have been introduced to detect cancer biomarkers to facilitate simple diagnosis.
DNA nanostructures and miRNAs as biomarkers
DNA has emerged as a promising material that allows researchers to construct novel designs as its structure could be predicted easily and accurately.[5] Examples of DNA nanostructures include nano-tweezers to detect norovirus and a DNA ‘Nano-Claw’ to detect membrane markers of cancer cells.[6],[7]
DNA Boolean logic gates have been constructed to produce signals in the presence of multiple targets, such as OR-gate and AND-gate DNA tetrahedra that generate fluorescence resonance energy transfer (FRET) signal when multiple inputs hybridize with the probe.[8]
As for the targets to be detected, different microRNAs (miRNAs) have been identified to be associated with cancers. For example, miR-15b-5p, miR-338-5p, and miR-764 found in plasma are potential biomarkers for detecting hepatocellular carcinoma cancer (HCC), a common type of liver cancer.[9] It has already been reported that it is promising to use these biomarkers - miRNAs to detect cancers.[10]
Objectives
In vivo synthesis of functional DNA nanostructure
Our aim is to design a novel DNA nanostructure that can detect multiple miRNA targets simultaneously. We hope that our design can discriminate a single base mutation of the target miRNAs. Hence, it can be highly specific to our targets and avoid false positives. Our goal is clear - we aim to design a tool which can possibly detect a combination of biomarkers and enhance the sensitivity of detecting a particular type of cancer.
Recently, in vitro applications of DNA nanostructure have already achieved point-of-care (POC) diagnosis[11]. Therefore, we hope to move from in vitro to in vivo by developing a self-assembled DNA nanostructure that can potentially target miRNAs in vivo. Detecting serum miRNA can be challenging because of the low serum miRNA level, so methods such as quantitative polymerase chain reaction are used to amplify the target miRNAs before detecting them.[12] We hope that our DNA nanostructure, which is synthesized and assembled in vivo, can potentially eliminate the need of target amplification. In addition, our design has an advantage over the current designs of molecular beacon. Molecular beacon makes use of fluorophores and quenchers[13], which cannot be synthesized in vivo. Our design does not require the use of fluorophore and quencher and thus can work well inside cells. In addition, our DNA nanostructure can be produced at a lower cost as fluorophore and quencher are not used.
Current progress
Our design is a 3-dimensional structure that can be self-assembled from oligonucleotides. Our aim is to construct a nanostructure that is able to detect multiple miRNA biomarkers such that it can reach a higher accuracy for diagnosis. For the selection of biomarkers, we are looking for a combination of miRNAs that are specific to a certain type of disease including cancers.
At current stage, we are testing different designs in vitro to see if they can produce desired signals. After proving our designs can work in vitro, we will attempt to test them in vivo. Finally, we will design a mechanism such that E. coli can synthesize the required oligonucleotides to form the specified nanostructure.
Signifcance
A leap forward - in vivo synthesis of 3D functional DNA nanostructures
In the past decade, functional DNA nanostructures have been used in similar in vitro approaches to detect various cancer biomarkers.[14][15]It is noted that most of those designs were applied in vitro. Recently, 1D and 2D DNA structures were successfully expressed and assembled in vivo,[16] while several novel 3D DNA structures were synthesized to produce signals in vivo.[17],[18] Given these advancements, our ultimate goal is to enable our functional DNA nanostructure to be synthesized and self-assembled in E. coli, that can function inside the disease cells. This, if successful and with further refinement, could be a great replacement to colour coded surgery in the surgical field.[19]
Last but not least, the cost and quality of production, efficiency and accuracy of our intracellularly-synthesized 3D structure will be compared to current diagnostic methods.
References
- ↑ American Cancer Society. (2015). Global Cancer Facts & Figures. Retrieved from http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-044738.pdf
- ↑ Public Health England. (2014). National Cancer Intelligence Network Cancer survival in England by stage. Retrieved from http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/survival#ref-3
- ↑ Pereira, B., Chin, S., Rueda, O. M., Vollan, H. M., Provenzano, E., Bardwell, H. A., Pugh, M., et al. (2016). The somatic mutation profiles of 2500 primary breast cancers refine their genomic landscapes. Nature Communications
- ↑ Pereira, B., Chin, S. F., Rueda, O. M., Vollan, H. K. M., Provenzano, E., Bardwell, H. A., ... & Tsui, D. W. (2016). The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nature communications, 7.
- ↑ Chen, Y. J., Groves, B., Muscat, R. A., & Seelig, G. (2015). DNA nanotechnology from the test tube to the cell. Nature nanotechnology, 10(9), 748-760.
- ↑ Nakatsuka, K., Shigeto, H., Kuroda, A., & Funabashi, H. (2015). A split G-quadruplex-based DNA nano-tweezers structure as a signal-transducing molecule for the homogeneous detection of specific nucleic acids. Biosensors and Bioelectronics, 74, 222-226.
- ↑ You, M., Peng, L., Shao, N., Zhang, L., Qiu, L., Cui, C., & Tan, W. (2014). DNA “nano-claw”: logic-based autonomous cancer targeting and therapy. Journal of the American Chemical Society, 136(4), 1256-1259.
- ↑ Pei, H., Liang, L., Yao, G., Li, J., Huang, Q., & Fan, C. (2012). Reconfigurable Three‐Dimensional DNA Nanostructures for the Construction of Intracellular Logic Sensors. Angewandte Chemie, 124(36), 9154-9158.
- ↑ Chen, Y., Chen, J., Liu, Y., Li, S., & Huang, P. (2015). Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Medical science monitor: international medical journal of experimental and clinical research, 21, 1864.
- ↑ Montani, F., & Bianchi, F. (2016). Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA. EBioMedicine, 5, 4-6.
- ↑ Hartman, Mark R., et al.(2013) . "Point-of-care nucleic acid detection using nanotechnology." Nanoscale 5.21 (2013): 10141-10154.
- ↑ Wang. W.T., Chen.Y.Q. (2014). "Circulating miRNAs in cancer: from detection to therapy." Journal of Hematology & Oncology. (2014): Vol.7. 86.
- ↑ TSOURKAS, Andrew, et al. (2003). Hybridization kinetics and thermodynamics of molecular beacons. Nucleic acids research, 2003, 31.4: 1319-1330.
- ↑ Miao, P., Wang, B., Chen, X., Li, X., & Tang, Y. (2015). Tetrahedral DNA nanostructure-based microRNA biosensor coupled with catalytic recycling of the analyte. ACS applied materials & interfaces, 7(11), 6238-6243.
- ↑ Li W. et. al. (2015). Highly selective and sensitive detection of miRNA based on toehold-mediated strand displacement reaction and DNA tetrahedron substrate. Biosensors and Bioelectronics. 71, 401-406.
- ↑ Elbaz, J., Yin, P., & Voigt, C. A. (2016). Genetic encoding of DNA nanostructures and their self-assembly in living bacteria. Nature communications, 7.
- ↑ Kim K. et. al. (2013). Drug delivery by self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells. Chem. Commun. 49, 2010-2012.
- ↑ Kim K. et. al. (2013). Sentinel lymph node imaging by a fluorescently labeled DNA tetrahedron. Biomaterials. 34, 5226-5235.
- ↑ Nguyen, Q. T., & Tsien, R. Y. (2013). Fluorescence-guided surgery with live molecular navigation [mdash] a new cutting edge. Nature reviews cancer, 13(9), 653-662.
